"10.1371_journal.pone.0047813","none","2012-10-23T00:00:00Z","Emily J Dhurandhar; Rashmi Krishnapuram; Vijay Hegde; Olga Dubuisson; Rongya Tao; X Charlie Dong; Jianping Ye; Nikhil V Dhurandhar","Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States of America; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America","Conceived and designed the experiments: NVD XCD JY EJD. Performed the experiments: EJD RT OD VH RK. Analyzed the data: EJD NVD VH. Contributed reagents/materials/analysis tools: XCD RT JY. Wrote the paper: EJD NVD VH JY XCD.","The following patents are granted or have been applied for: patent number 6,127,113: Viral obesity methods and compositions; patent number 6,664,050: Viral obesity methods and compositions; patent number U.S. 8,008,436B2, dated August 30, 2011: Adenovirus 36 E4orf1 gene and protein and their uses. Provisional patent filed: Adenovirus Ad36 E4orf1 protein for prevention and treatment of non-alcoholic fatty liver disease, July 2010. Provisional patent filed: Enhanced glycemic control using Ad36E4orf1 and AKT1 Inhibitor, January 2012. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2012","10","Emily J Dhurandhar","EJD",8,TRUE,4,5,3,5,TRUE,TRUE,FALSE,0,NA,FALSE
